Next Article in Journal
The Novel Anti-Cancer Agent, SpiD3, Is Cytotoxic in CLL Cells Resistant to Ibrutinib or Venetoclax
Previous Article in Journal
Chronic Myeloid Leukemia in Bulgaria in the New Millennium: Identification of Directions for Improvement in Management and Outcomes Reporting
 
 
Review

Article Versions Notes

Hemato 2024, 5(3), 277-320; https://doi.org/10.3390/hemato5030023
Action Date Notes Link
article pdf uploaded. 9 August 2024 15:34 CEST Version of Record https://www.mdpi.com/2673-6357/5/3/23/pdf-vor
article xml file uploaded 12 August 2024 08:00 CEST Original file -
article xml uploaded. 12 August 2024 08:00 CEST Update https://www.mdpi.com/2673-6357/5/3/23/xml
article pdf uploaded. 12 August 2024 08:00 CEST Updated version of record https://www.mdpi.com/2673-6357/5/3/23/pdf
article html file updated 12 August 2024 08:01 CEST Original file https://www.mdpi.com/2673-6357/5/3/23/html
Back to TopTop